Subcutaneous Immunotherapy (SCIT) with the New Polymerized Molecular Allergoid Alt a1: A Pilot Study in Children with Allergic Rhinitis Sensitized to Alternaria Alternata.
Giulia BrindisiAlessandra GoriCaterina AnaniaIvana MartinelliMartina CapponiGiovanna De CastroAnna Maria ZicariPublished in: Journal of clinical medicine (2023)
The new SCIT for Alt a1 significantly improves AR symptoms from a subjective, objective point of view and laboratory and functional parameters.